Khushali Pandit/LinkedIn
May 14, 2026, 06:39
Khushali Pandit: Innovations in Cell Therapy Manufacturing Highlighted at ISCT 2026
Khushali Pandit, Quality Assurance Quality Control Manager at CAR T Cell Therapy Centre at Tata Memorial Hospital, shared a post on LinkedIn:
“Proud to see our work being showcased at the ISCT, International Society for Cell and Gene Therapy Conference2026 – poster presentation and an elevator pitch presentation.
Congratulations to my colleague Naitika Bhavsar for presenting the work on APC-independent iNKT cell expansion strategies, contributing towards scalable and accessible cell therapy approaches.”
Stay updated with Hemostasis Today.
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same
-
Jun 28, 2026, 19:05Andrea Cesari: Comparing Catheter-Based Reperfusion Strategies for Intermediate-High-Risk PE
-
Jun 28, 2026, 19:02Nassim Emteir: Interpreting TSAT with Ferritin to Guide Iron Deficiency Diagnosis and Treatment
-
Jun 28, 2026, 19:00Andrew Jackson: Predicting PICC-Related Venous Thrombosis in Patients Undergoing Radiotherapy
-
Jun 28, 2026, 10:34Heghine Khachatryan: Menarche as the First ‘Bleeding Challenge’
-
Jun 28, 2026, 10:13Mohammed Alharbi: Assessing Warfarin Management and Anticoagulation Quality in Older Populations
-
Jun 28, 2026, 10:03Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients